FIELD: medicine, pharmaceutics.
SUBSTANCE: described are new compounds of formula 
with their radical values specified in the patent claim, as well as their pharmaceutically acceptable salts exhibiting VEGFR-2 receptor KDR-kinase inhibitor activity, and drugs based on such compounds. Described is an intermediate product for preparing the compound of formula (I), and the use of this intermediate product.
EFFECT: development of an effective method for preparing the compound.
41 cl, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTHRANYLAMIDEPYRIDINE AMIDES WITH SELECTIVE EFFECT AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | 2002 |
|
RU2299208C2 |
| NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINAL AGENTS AND PHARMECEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES | 2003 |
|
RU2378259C2 |
| NEW PYRIMIDINE DERIVATIVES | 2011 |
|
RU2528386C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | 2005 |
|
RU2406725C2 |
| NEW PHTHALAZINONE DERIVATIVES AS AURORA A KINASE INHIBITORS | 2005 |
|
RU2397166C2 |
| N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
| 5-AMINO-4,6-DISUBSTITUTED INDOLE AND 5-AMINO-4,6-DISUBSTITUTED INDOLINE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | 2008 |
|
RU2483060C2 |
| 1,3-DIARYL-SUBSTITUTED UREAS AS KINASE ACTIVITY MODULATORS | 2006 |
|
RU2402544C2 |
| HETEROCYCLIC COMPOUNDS AS PESTICIDES | 2013 |
|
RU2641916C2 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
